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Abstract 
We have recently shown that at isotopic steady state 13C NMR can provide a direct measurement of 
glycogen concentration changes, but that the turnover of glycogen was not accessible with this protocol. 
The aim of the present study was to design, implement and apply a novel dual-tracer infusion protocol 
to simultaneously measure glycogen concentration and turnover. After reaching isotopic steady state for 
glycogen C1 using [1-13C] glucose administration, [1,6-13C2] glucose was infused such that isotopic steady 
state was maintained at the C1 position, but the C6 position reflected 13C label incorporation. To 
overcome the large chemical shift displacement error between the C1 and C6 resonances of glycogen, 
we implemented 2D gradient based localization using the Fourier series window approach, in 
conjunction with time-domain analysis of the resulting FIDs using jMRUI. The glycogen concentration of 
5.1 ± 1.6 mM measured from the C1 position was in excellent agreement with concomitant biochemical 
determinations. Glycogen turnover measured from the rate of label incorporation into the C6 position of 
glycogen in the α-chloralose anesthetized rat was 0.7 μmol/g/h.  
Introduction 
Glycogen (Glyc) is a macromolecule consisting of linked glycosyl units that serves as a storage 
molecule for glucose (Glc) in the body. Since it has a much lower concentration in the brain than in 
tissues such as muscle and the liver, its role as a cerebral energy store has been largely neglected, 
although over the last decade interest has been renewed for several reasons: not only does it appear 
play an active role in brain energy homeostasis (1), it is also involved in such processes as memory 
formation (2) and neurotransmitter synthesis (3). Additionally, it has been implicated in hypoglycemia 
unawareness, a dangerous complication often encountered in patients treated with exogenous insulin 
(4). 
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Glycogen concentrations are the result of the simultaneous action of its synthesis and catalysis (i.e. 
turnover), resulting in a well-regulated level of brain glycogen in the resting state. In order to gain 
insight into the role of glycogen in the abovementioned processes, it is important to determine 
concentration and metabolic rates.  
Metabolism of glycogen can be assessed by measuring the incorporation of its precursor glucose 
that has been labeled with an isotope like 13C, 3H or 14C. From the time or rate of label incorporation, 
turnover times or rates can be determined. Currently, the only method to measure label incorporation 
into glycogen non-invasively in vivo is 13C nuclear magnetic resonance (NMR)(1). Following the infusion 
of 99% isotopically enriched (IE) [1-13C1] Glc, incorporation of 13C label into Glyc can be measured (5). 
However, such measurements of 13C label incorporation may be due to increased Glyc IE or due to a net 
increase in Glyc concentration.  
We have previously shown that the absolute concentration of brain Glyc can be determined from 
the C1 resonance by 'prelabeling' with [1-13C] Glc, i.e. providing the animal exclusively with food that 
only contains [1-13C] Glc as a source of carbon prior to the experiment (6): when the enrichment at C1 
reached steady state, the IE of N-acetylaspartate (NAA) was used to determine the IE of Glyc in vivo. This 
approach allowed the measurement of the Glyc concentration, but provided no information on 
turnover.  
However, if after this prelabeling [1,6-13C2] Glc is infused at the IE of the Glyc C1 resonance, the C1 
resonance will remain in isotopic steady state and will act as a pure concentration change monitor, 
while the C6 resonance signal will increase mostly due to label incorporation, and can in principle be 
monitored to determine the turnover time. The aim of the present study was therefore to establish the 
simultaneous measurement of the glycogen C1 and C6 resonances, such that the C1 resonance can be 
used to determine concentration and the C6 resonance can be used to determine the turnover time. 
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One of the challenges of measuring the Glyc C1 and C6 resonances simultaneously is that they are 
separated by ~4 kHz at 9.4 T due to their chemical shifts of 100.5 and 61.4 ppm respectively. Such a 
large frequency difference represents a formidable challenge for 3D spatial localization using gradient-
based methods, to date the only method capable of measuring NMR of Glyc in the brain. To overcome 
chemical shift displacement (CSD), one of the goals of the present study was therefore to implement a 
new gradient-based localization sequence that aimed to minimize CSD: the two-dimensional Fourier 
series window (FSW, (7)).  
Fourier series window (FSW) based pulse sequences have been used mostly for 31P NMR in muscle 
and liver (8-10). The FSW is an alternative to traditional Fourier transform chemical shift imaging (CSI). A 
predetermined voxel shape is chosen for which a single window W (the voxel) of resolution N is 
generated by summation of 2N+1 phase-encoded FIDs that are multiplied by a series of matching 
Fourier coefficients βn (see appendix A for a recapitulation of FSW theory).  
The FSW localization approach can be tailored to achieve arbitrary voxel shapes , has low cross-voxel 
contamination and a complete lack of chemical shift displacement (11). The number of repetitions per 
phase encoded FID should correspond to the Fourier coefficient's relative weight; a phase encode with a 
low Fourier coefficient will need only a few averages, while a high coefficient should imply many 
averages for efficient performance. The FSW approach is thus ideally suited for applications that require 
many averages as is the case for 13C NMR of glycogen. 
Therefore the aim of the present study was two-fold: first to implement a localization scheme based 
on the 2D Fourier series window to minimize chemical shift displacement, and second to establish a 
dual-isotope protocol using [1,6-13C2] glucose and to determine the glycogen turnover time while 
monitoring its concentration. 
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Methods 
NMR instrumentation 
All experiments were performed using an actively shielded 9.4 T 31 cm horizontal-bore Varian 
spectrometer with high-performance gradients (400 mT/m in 130 μs). A custom-built 3-loop 10 mm 
diameter surface coil was used for 13C excitation and detection, while quadrature 14 mm 1H coils were 
used for positioning, shimming and decoupling (12). Shimming was performed with FASTMAP (13). 
FSW pulse sequence 
The total delay for the gradients to play out between the excitation pulse and the start of the acquisition 
was 270 μs (Fig. 1), which should result in less than 3% signal loss due to the estimated glycogen T2 of 10 
ms (14). Slice selection in the third dimension was achieved using one-dimensional ISIS (15), using a 6 ms 
hyperbolic secant pulse to select a slice of 1 cm thickness. A minimum of two averages was thus 
required per gradient setting. We propose the acronym FOSSIL (FOurier Series-based Spectroscopic 
Imaging Localization) for this 2D FSW-based pulse sequence.  
WALTZ-16 broadband NOE and decoupling were applied at the 1H water frequency (16). A 3 ms 90° 
BIR-4 pulse (17) was used for excitation, with a nominal bandwidth of 5 kHz at 2.5 kHz γB1max, sufficient 
to cover the 3.9 kHz frequency difference between the Glyc C1 and C6 resonances (Fig. 2). The BIR-4 
pulse has a semi-linear phase variation that increasingly varies near the edges of its nominal bandwidth.  
The Fourier coefficients were calculated (see appendix) for a square two-dimensional Fourier series 
window in two dimensions with a field of view (FOV) of 22 x 22 mm2. For a window resolution of 1/5 
FOV (4.4x4.4 mm2) and N=5 coefficients this resulted in (2N+1)2=121 phase encodes, while for 1/8 FOV 
(2.75x2.75 mm2) and N=8 coefficients it resulted in 289 phase encodes. Each of these phase encodes 
had its number of acquisitions adapted to its 2D Fourier coefficient βn (Eq. A.5 in the appendix). 
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Validation of FSW localization in phantom experiments 
To verify the localization accuracy of the FSW sequence, we used a seven-compartment phantom, 
consisting of a water-filled Perspex half-cylinder in which 6 tubes with different solutions were 
mounted. The tubes contained saturated solutions of either bicarbonate (of which the carboxyl carbon 
resonates at 168.9 ppm), formate (174.0 ppm), carbonate (161.1 ppm) or acetate (182.2 ppm). 
To account for the long T1 relaxation time of the carboxyl groups (6-30 s) the repetition time was 10 
s. The average number of acquisitions per gradient setting was 12, adjusted according to the relative 
coefficient weight (see appendix). 
In vivo measurements 
To determine the brain Glyc turnover rates and concentrations, six Sprague-Dawley rats (~225 g, Charles 
River Laboratories, France) were fasted overnight (Fig. 3). The next morning, for 24 hours before the 
start of the NMR experiments, they were fed 100% enriched, 10% w/v [1-13C1] Glc in tap water ad 
libitum to achieve isotopic steady state for the Glyc C1 resonance as described previously (6).  
On the day of the NMR measurement, the animal was anesthetized with 2% isoflurane. Both 
femoral veins and a femoral artery were catheterized for infusion of glucose and α-chloralose, and 
blood-gas analysis respectively. After surgery, anesthesia was switched to α-chloralose (an initial bolus 
of 80mg/kg followed by continuous infusion of 50mg/kg/h with 5mg/ml α-chloralose in saline) under 
assisted breathing, and the animal was placed in the NMR scanner where its temperature was kept at 
37.5 ± 0.5 °C with circulating warm water. While the animal was in the scanner, blood samples were 
taken for blood-gas and glycemia analysis every 30 min to monitor physiology.  
Glycogen NMR studies 
Two sets of 'baseline' datasets with the FSW-based sequence were acquired to determine the glycogen 
7 
 
and glucose levels at steady state. With a repetition time of 1 s, averaging of the phase encodes at 5 
coefficients per dimension for a 1/5 FOV window (see appendix) was calculated such that the total 
acquisition time was 59 min (see appendix). The 13C carrier frequency was placed in the center of the 
Glyc C1 and C6 resonances, while broadband decoupling was applied at the Glc 1H frequency.  
After these baseline acquisitions, a bolus of 0.6 mg/kg [1,6-13C2] Glc whose IE matched that of Glyc 
C1 was given over 5 min, and a variable-rate infusion of [1,6-13C2] Glc was used afterwards to maintain 
blood Glc level at 10 mM. Seven more 5x5 FSW datasets were then acquired with a temporal resolution 
of 1 h.  
After the study, the animal was sacrificed using 2 s of focused 4 kW microwave radiation (Gerling 
Applied Engineering, Modesto, CA). The brain was taken out and stored at -80 °C for later biochemical 
determination of Glyc content and high resolution NMR determination of Glyc IE.  
A phantom containing 500 mM Glyc (Sigma-Aldrich, St. Louis, MO) and 5 mM [1-13C] Glc was then 
placed under the coil at T = 37 °C, and another set of 5x5 FSW was acquired for absolute quantification 
purposes as described previously (6).  
Isotopic enrichment 
The IE of the steady state Glyc C1 position was determined in vivo to match the IE of infused Glc to this 
IE and thus to keep the Glyc C1 IE constant. Since the steady state IE of glycogen using this protocol is 
2.2 times that of N-acetylaspartate (NAA) (6), the NAA IE was determined by comparing the 13C-coupled 
1H NAA doublet signals to that of the 12C-coupled 1H NAA singlet in a modified ACED-STEAM (18) 
sequence as described previously (6). 
Brain extract measurements 
The extracted brains were homogenized and prepared for Glc concentration measurement as well as 
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verification of the IE as previously described (19). Briefly, after powderizing the brain by mortar and 
pestle, 200 μl of 0.03 M sodium acetate was added, which was then homogenized with an ultrasonic 
processor. The sample was divided into two aliquots, one of which was incubated at 37 °C with α-1,4- α-
1,6-glucosidase, while the other was incubated with a saline solution. From the glucose content 
measured in a glucose analyzer (GM7 Micro-stat, Analox Instruments, London, UK), one aliquot 
effectively gave the summed glucose and glycogen concentration, while the other gave the free tissue 
glucose concentration. After filtering, lyophilizing and resuspension in D2O, high-resolution 1H NMR 
spectra of these samples were obtained at 600 MHz. The ratio of the 13C bound doublet and 12C-bound 
singlet were used to calculate the IE of free glucose in one aliquot, and the concentration-weighted 
average IE of Glc and Glyc in the other. The free glucose IE was then used to calculate the Glyc IE from 
the concentration-weighted average IE of Glc and Glyc using Eq. 3 from Ref. (6). 
Spectral processing 
The calculation of the localized FIDs from the coefficient weighted individual FSW FIDs was done in 
MATLAB (The Mathworks Inc., Natick, MA, USA) using Eq. A.3 in the appendix. The datasets were 
reconstructed into a grid of 16x16 to allow the selection of an optimally positioned voxel for every 
study. The resulting FIDs were subsequently DC corrected and multiplied with a 15 Hz exponential 
decay.  
The localized FIDs were processed in the time-domain using the jMRUI software package (20,21). A 
frequency filter was applied to select the chemical shift range from 47 to 110 ppm. A total of 10 signal 
components were fitted using AMARES (Advanced Method for Accurate, Robust, and Efficient Spectral 
fitting) (22): Glyc C1, Glc C1β, Glc C1α, glycerol C1, Glc C6, Glyc C6, a peak each for glutamine C2, 
glutamate C2 and aspartate C2 , plus a term accounting for any residual DC offset. The linewidths of 
glucose (C1α, C1β and C6) were constrained to be equal, and the linewidths of Glyc C1 and C6 were 
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constrained to be equal. These constraints on Glyc C6 and Glc C6 allowed to separately quantify the 
overlapping C6 resonances of Glc and Glyc. Since the phase of each individual resonance was stable 
throughout the experiment, the phase was estimated for each animal from the summed time series; the 
phase however varied along the spectrum due to the phase profile of the BIR-4 excitation pulse (Fig. 2a). 
To minimize the influence of the broad baseline components, the first 10 data points of the signals were 
weighted with a quarter-sine wave (22).  
Quantitation and turnover calculation 
Absolute concentrations of Glc C1, Glyc C1 and Glyc C6 were calculated from the in vivo and phantom 
signals S, the signals of the formic acid reference phantom in both situations (to correct for RF loading) 
and a correction factor α for differences in NOE and partial T1 relaxation as in previous studies ( (23) and 
references therein). This results in: 
ph
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iv Gl
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S
Gl ][
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,,
,
,
,  .       (1) 
Here the Gl and FA are glucose/glycogen and formic acid, while iv and ph are in vivo and phantom. 
OriginPro (OriginLab Corporation, Northampton, MA, USA) was used to fit the concentration time 
courses. Glyc C6 was fitted with an exponential increase (C(t)=[Glyc]C6*exp[-t/τ]), while the Glc C1 and 
Glyc C1 time courses were fitted with constants, as there was no time dependence discernible. 
Results 
The localization ability of the 2D FSW sequence was tested on a phantom containing bicarbonate, 
formate, carbonate and acetate (Fig. 4). Despite the range of 20 ppm in chemical shift, the FSW signals 
of a formate, carbonate and acetate compartment overlap with their 1H image equivalents, as evidenced 
from the FSW color maps of the resonances projected on top of a 1H gradient echo image (Fig. 4b). Note 
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that the compartments that were more than ~10 mm away from the surface coil plane were outside the 
sensitive volume of the small 13C coil and thus not detected. 
Localization of the 2D FSW sequence was further tested in vivo. Since it is well established that 13C 
resonances from lipids originate outside the brain, good localization should eliminate lipid-specific 
resonances. When placing the voxel of interest (VOI) into superficial regions encompassing fat and 
muscle, clearly resonances ascribed to extra-cerebral fat (glycerol C1,3 at 62.5 ppm) were detected (Fig. 
5b). Moving the VOI into the brain minimized the glycerol resonance (Fig. 5c).  
The bandwidth of the BIR-4 pulse was ~5 kHz, sufficient to simultaneously excite the Glyc C1 and C6 
resonance with less than 10% signal loss, according to simulations (Fig. 2) and verified in phantom 
studies. Since the RF coil's RF loading varied per subject, the effective power for the 90° BIR-4 RF pulse 
was varied slightly each time, causing the zero and first order phase of the spectra to vary slightly from 
study to study, as expected from the pulse profile (Fig. 2b). Therefore, while the magnitude of the 
excited signal for the resonances of interest was comparable across all studies, the phase over the entire 
spectrum varied up to 70°. Especially the phase of the Glyc C1 and Glyc/Glc C6 resonances, while stable 
per subject, showed large variations across subjects. Nonetheless, the signal-to-noise ratio of the 
localized spectra was in all cases high enough to allow robust fitting using the time-domain AMARES 
fitting routine, including the aforementioned phase variations, resulting in negligible residuals over the 
spectral regime of interest (Fig. 6).  
The time courses of the Glyc and Glc C1 signal were within experimental error constant, consistent 
with the isotopic steady-state achieved using this protocol (Fig. 7). For the quantitation, both C1 
resonances were corrected for the IE (measured from NAA as in our previous study), which was 
established at IEGlyc,inv = 42 ± 6%. The in vivo IE determination was within a few percent comparable to 
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that in brain extracts (as previously, (6)): a linear fit through the origin resulted in 
IEGlyc,invivo=1.03·IEGlyc,highres (R2=0.98, P=0.16).  
From the thus determined IE of Glyc and the [1-13C] Glyc concentration measured by in vivo NMR, 
the total concentration of glycogen and glucose was calculated using Eq. 1, resulting in total Glc and Glyc 
concentrations of [Glc]t,C1 = 4.3 ± 1.0 and [Glyc]t,C1 = 5.1 ± 1.6 mM respectively. Here the subscript t 
stands for total, while C1 indicates that the concentration was based on the integral of the C1 
resonance. The determined glycogen concentrations were within experimental error identical to that 
determined by concomitant biochemical assays, which yielded [Glyc]t,assay = 5.3 ± 1.6 mM.  
The Glc C6 signal increased in a step-like manner to reach steady state levels within 30 min after the 
start of the [1,6-13C2] Glc infusion at t = 0, whereas the Glyc C6 signal slowly increased over time. Given 
that the stability of Glyc C1 indicated minimal concentration changes, this gradual increase in the Glyc 
C6 signal therefore mainly represents changes in the IE of Glyc C6, and thus can be used to estimate 
glycogen turnover time. An exponential fit of the Glyc C6 signal with C(t)= [Glyc]C6·exp(-t/τ) resulted in a 
turnover time of 8 ± 4 h (R2 = 0.97) and a steady state Glyc C6 concentration of [Glyc]C6 = 3 ± 1 mM. 
Dividing the steady state concentration of the Glyc C6 time course by its IE (assuming the same C6 IE at 
steady state as the C1 resonance) resulted in a total glycogen concentration [Glyc]t,C6 = 7 ± 3 mM. By 
dividing the average [Glyc]t by τ we calculated a Glyc turnover rate of 0.7 ± 0.6 μmol/g/h. 
Discussion 
In this study we implemented and used the Fourier series window approach for the first time for 2D 
localization of 13C signals, which, combined with a novel dual isotope infusion protocol, allowed the 
simultaneous determination of glycogen concentration and turnover. 
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While the dephasing that the phase encoding generates implies that the 2D FSW pulse sequence is 
theoretically not as efficient as single-voxel localized spectroscopy, the sequence does have the same 
efficiency equivalent to conventional spectroscopic imaging, provided that the amount of acquisitions 
per gradient setting are weighted by their Fourier coefficient. Therefore, the SNR per time unit observed 
in the present study was ~70% that of single-voxel 13C spectroscopy studies (6,16). The sequence 
appears to be a suitable alternative for regular spectroscopic imaging or localized spectroscopy if large 
chemical shift ranges are to be localized, provided sufficient averaging is performed. 
Time-domain fitting of the spectra was robust: the phase variations across the chemical shift of the 
FSW spectra were expected from the simulations of the BIR-4 pulse and were easily accounted for by 
the AMARES routine. The step-like increase of Glc C6 at the start of the infusion together with the slow 
increase of Glyc C6 over time indicated that their resonances were robustly deconvolved based on their 
substantially different linewidths, despite Glyc and Glc C6 having considerable spectral overlap.  
The 2D FSW pulse sequence was combined with the isotopic enrichment (IE) determination and 
external reference quantification to obtain absolute quantifications of Glyc. IE determination was in 
excellent agreement with previous results (6,23), and the in vitro biochemistry and high resolution 1H 
NMR confirmed the validity of the in vivo method. 
The absolute quantification of the C1 resonance resulted in total Glc and Glyc concentration time 
that were constant over time, indicating stable Glyc and Glc concentrations, the former validated by 
biochemical in vitro analysis and in agreement with previously reported levels under similar 
hyperglycemic and anesthetic conditions (19). Due to the slightly hyperglycemic level at which the blood 
glucose was maintained, a slight increase in the Glyc concentration over time could also have been 
expected. This was however not observed, which may be due to SNR being too low to detect such a 
small increase: a linear Glyc C1 time course fit in which the slope was left free resulted in a slope of -
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8x10-4 ± 0.25 mM/h, showing that a glycogen concentration increase of at least 0.5 mM/h was necessary 
to be statistically significant.  
Conclusions 
We conclude that a) Glyc C1 and C6 can be simultaneously measured in vivo using the Fourier series 
window based pulse sequence, and that b) the dual isotope infusion protocol proposed can be used to 
simultaneously determine both the glycogen concentration and turnover in vivo. 
Appendix: FSW theory and calculations 
The Fourier series window approach has in NMR mostly been used for 31P spectroscopic imaging. A 
more in-depth treatment of the theoretical background can be found in Refs (7,9,11,24). For 
convenience, a short overview of this theory is given in this appendix. 
In a one-dimensional FSW pulse sequence a predetermined window shape W (the voxel) is chosen 
with a resolution N and window width FOV/N. A phase encoding gradient is applied to the transverse 
magnetization such that distance becomes equivalent to the phase φ. The window itself can then be 
described as a set of 2N+1 Fourier coefficients βn such that in the one-dimensional case it looks like (7):  



N
N
in
neW
)( .         (A.1) 
To determine the coefficients βn, one can reverse Eq. 1 and integrate from –π to π: 


 inn eWd

 )(2
1
.         (A.2) 
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To not repeat the window inside the field of view (FOV), the first coefficient β1 is set to have an 
accompanying phase encoding step which has a phase spread of 180° over the FOV. When applied to 
the spatially encoded MR signal ),( tr

 , the window is convolved with a series of phase-encoded FIDs 
S(n,t): 



N
N
n tnSWtrrd ),()(),( 

.        (A.3) 
The window can be arbitrarily shifted a distance ψ by multiplying the window with ine (i.e. Fourier 
shifting). The windowed spatially encoded time-domain signal is now: 
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.   (A.4) 
With these equations the parameters for the window of choice can be calculated. In these studies, a 
square window shape was chosen, so Eq. 2 was solved for the square shape with width w, resulting in 
1D coefficients βn: 


n
nw
n
)2/sin(
 .    n = -N,-N+1,…,0,…N-1,N    (A.5) 
The 2N+1 coefficients for the phase encoding combinations can now be calculated. N is usually 
chosen such that the resolution is FOV/N. The resulting voxel is only approximately rectangular due to 
truncation by the finite number of coefficients. However, terminating the coefficient function of Eq. 4 at 
the first zero crossing (i.e. where n = ±2π/w) substantially reduces any truncation effects(24). The shape 
of the window results in a slightly larger area than its nominal width, yet 99% of the window intensity 
drops off at 1.4 times the window width. The 2D FSW separately applies the above equations to the 
second dimension coefficients βm as well, resulting in (2N+1)2 doubly weighted phase encodes. 
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Figure Captions  
 
Figure 1. Diagram of the FOSSIL pulse sequence. The 90° BIR-4 pulse is preceded by a 1D ISIS module 
for slice selection. The time between the BIR-4 and the acquisition was 270 μs, while the repetition time 
was 10 s for the phantom and 1 s for the rat. 
 
Figure 2. Simulated characteristics of a 3 ms 90° BIR-4 adiabatic pulse. a) Resonance offset versus 
phase offset at different values of γB1max, with horizontal markers at 4 kHz bandwidth. Not far outside 
the bandwidth, the relation becomes incoherent. b) Resonance offset versus magnetization in the 
transverse plane at 2.5 kHz; outside a bandwidth of roughly 4.5 kHz the flip angle becomes incoherent. 
18 
 
c) Pulse power versus magnetization in the transverse plane. 2 kHz γB1max appears to be sufficient power 
for all offsets. 
 
Figure 3. Overview of the experimental protocol and its timing. After fasting, the animal is 
prelabeled with C13 glucose, prepared for the study and inserted in the scanner, where its IE is 
determined. The main study itself then starts and lasts until sacrifice. After the study a phantom is 
inserted for absolute quantification purposes.  
Fast Prelabel Prep IE Measurement Quant
Overnight 24 h 30 min1 h 9 h 1 h
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Figure 4. The localization capacity of the FSW sequence. a) Schematic drawing of the 30 mm wide 
and 52 mm long half-cylindrical localization phantom. The compartment diameters and solutions are: I. 
6 mm filled with bicarbonate, II. 4 mm filled with formate, III. 5 mm filled with carbonate IV. 6 mm filled 
with acetate V. 4 mm filled with bicarbonate and VI. 4 mm filled with formate. The detection coil was 
placed on top of the phantom. b) Thresholded 13C FSW color maps of the different resonances have 
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been projected on top of a 1H gradient echo image. From left to right the color maps are formate, 
carbonate and acetate, all scaled to fit the same color range. The locations of the individual 
compartments can be seen in the gradient echo image, as can parts of the formic acid-filled bubble at 
the center of the coil. 
 
Figure 5. Demonstration of the FSW sequence localization capability. a) 1H gradient echo image with 
the same FOV size as the FSW sequence (22x22 mm2) and the positions of two windows indicated with 
white rectangles. b) Example of a localized spectrum in the brain. Note the presence of cerebral 
metabolites and the large glucose/glycogen peak. c) Localized spectrum outside the brain; in this case in 
the skin. Notice that the relative contribution of the glycerol is much bigger than that of glycogen and 
glucose C6, which still has a small presence due to the partial location of the voxel in the brain.  
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Figure 6. jMRUI fitting of a FSW brain spectrum after 6 h of infusion. Bottom: spectrum and fit. 
Middle: individual peaks with their names. Top: fit residual. Image: location of the window within the 
brain, with a formic acid phantom visible at the center of the detection coil.  
 
Figure 7. Time courses of the peaks. The two baseline FSW sets are represented as t = -1 and 0. Later 
points are taken at the time halfway through their measurement, e.g. the first measurement after the 
C1,6 infusion start is taken as t = 0.5 h. Note that the Glc C6 is not quantified and thus has an arbitrary 
scale. 
